SANG CHARLES 4
4 · Adaptive Biotechnologies Corp · Filed Feb 18, 2020
Insider Transaction Report
Form 4
SANG CHARLES
Sr VP, Clinical Diagnostics
Transactions
- Award
Stock Option (Right to Buy)
2020-02-13+40,000→ 40,000 totalExercise: $31.71Exp: 2030-02-13→ Common Stock (40,000 underlying)
Footnotes (1)
- [F1]The options vest with respect to 1/4 of such shares on February 13, 2021, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested.